Elben Guimaraes

Each approach has its advantages and drawbacks. This guide should help you decide which one, or perhaps a hybrid strategy, is best for your company. Exploring Strategies For Developing Robust AAV Platforms Explore advanced AAV production platforms that enhance efficiency, scalability, and compliance, paving the way for safe and accessible gene therapies.

Skip the back-and-forth emails with your analytics services provider with the help of KBI Biopharma’s Analytics Portal -- your single access point for quoting, ordering, sample submission, project status tracking, and data access. No more emails. Just log in, get what you need, and keep your project moving forward. Simplify Your Workflow – Explore the Analytics Portal. The choice is not straightforward and each approach has its advantages and drawbacks.

On-Demand Webinar - The Road to Approval: Viral Clearance Strategies for Non-Enveloped Viral Vectors Did you know that the ICH Q5A(R2) guideline is now including the expectation for viral clearance studies for non-enveloped viral vectors? Watch this webinar to get the keys to design a successful study for your AAV products. Each approach has its advantages and drawbacks, making the decision-making process crucial for your organization.